Rohto Pharmaceutical Co Ltd
TSE:4527

Watchlist Manager
Rohto Pharmaceutical Co Ltd Logo
Rohto Pharmaceutical Co Ltd
TSE:4527
Watchlist
Price: 2 808.5 JPY 2.31% Market Closed
Market Cap: 642.5B JPY
Have any thoughts about
Rohto Pharmaceutical Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Rohto Pharmaceutical Co Ltd stock under the Base Case scenario is 3 343.8 JPY. Compared to the current market price of 2 808.5 JPY, Rohto Pharmaceutical Co Ltd is Undervalued by 16%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
3 343.8 JPY
Undervaluation 16%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Rohto Pharmaceutical Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Rohto Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Rohto Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Rohto Pharmaceutical Co Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Rohto Pharmaceutical Co Ltd

Provide an overview of the primary business activities
of Rohto Pharmaceutical Co Ltd.

What unique competitive advantages
does Rohto Pharmaceutical Co Ltd hold over its rivals?

What risks and challenges
does Rohto Pharmaceutical Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Rohto Pharmaceutical Co Ltd.

Provide P/S
for Rohto Pharmaceutical Co Ltd.

Provide P/E
for Rohto Pharmaceutical Co Ltd.

Provide P/OCF
for Rohto Pharmaceutical Co Ltd.

Provide P/FCFE
for Rohto Pharmaceutical Co Ltd.

Provide P/B
for Rohto Pharmaceutical Co Ltd.

Provide EV/S
for Rohto Pharmaceutical Co Ltd.

Provide EV/GP
for Rohto Pharmaceutical Co Ltd.

Provide EV/EBITDA
for Rohto Pharmaceutical Co Ltd.

Provide EV/EBIT
for Rohto Pharmaceutical Co Ltd.

Provide EV/OCF
for Rohto Pharmaceutical Co Ltd.

Provide EV/FCFF
for Rohto Pharmaceutical Co Ltd.

Provide EV/IC
for Rohto Pharmaceutical Co Ltd.

Show me price targets
for Rohto Pharmaceutical Co Ltd made by professional analysts.

What are the Revenue projections
for Rohto Pharmaceutical Co Ltd?

How accurate were the past Revenue estimates
for Rohto Pharmaceutical Co Ltd?

What are the Net Income projections
for Rohto Pharmaceutical Co Ltd?

How accurate were the past Net Income estimates
for Rohto Pharmaceutical Co Ltd?

What are the EPS projections
for Rohto Pharmaceutical Co Ltd?

How accurate were the past EPS estimates
for Rohto Pharmaceutical Co Ltd?

What are the EBIT projections
for Rohto Pharmaceutical Co Ltd?

How accurate were the past EBIT estimates
for Rohto Pharmaceutical Co Ltd?

Compare the revenue forecasts
for Rohto Pharmaceutical Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Rohto Pharmaceutical Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Rohto Pharmaceutical Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Rohto Pharmaceutical Co Ltd compared to its peers.

Compare the P/E ratios
of Rohto Pharmaceutical Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Rohto Pharmaceutical Co Ltd with its peers.

Analyze the financial leverage
of Rohto Pharmaceutical Co Ltd compared to its main competitors.

Show all profitability ratios
for Rohto Pharmaceutical Co Ltd.

Provide ROE
for Rohto Pharmaceutical Co Ltd.

Provide ROA
for Rohto Pharmaceutical Co Ltd.

Provide ROIC
for Rohto Pharmaceutical Co Ltd.

Provide ROCE
for Rohto Pharmaceutical Co Ltd.

Provide Gross Margin
for Rohto Pharmaceutical Co Ltd.

Provide Operating Margin
for Rohto Pharmaceutical Co Ltd.

Provide Net Margin
for Rohto Pharmaceutical Co Ltd.

Provide FCF Margin
for Rohto Pharmaceutical Co Ltd.

Show all solvency ratios
for Rohto Pharmaceutical Co Ltd.

Provide D/E Ratio
for Rohto Pharmaceutical Co Ltd.

Provide D/A Ratio
for Rohto Pharmaceutical Co Ltd.

Provide Interest Coverage Ratio
for Rohto Pharmaceutical Co Ltd.

Provide Altman Z-Score Ratio
for Rohto Pharmaceutical Co Ltd.

Provide Quick Ratio
for Rohto Pharmaceutical Co Ltd.

Provide Current Ratio
for Rohto Pharmaceutical Co Ltd.

Provide Cash Ratio
for Rohto Pharmaceutical Co Ltd.

What is the historical Revenue growth
over the last 5 years for Rohto Pharmaceutical Co Ltd?

What is the historical Net Income growth
over the last 5 years for Rohto Pharmaceutical Co Ltd?

What is the current Free Cash Flow
of Rohto Pharmaceutical Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Rohto Pharmaceutical Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Rohto Pharmaceutical Co Ltd

Current Assets 204.9B
Cash & Short-Term Investments 64.5B
Receivables 68.5B
Other Current Assets 71.9B
Non-Current Assets 203.4B
Long-Term Investments 48B
PP&E 88.5B
Intangibles 58B
Other Non-Current Assets 8.9B
Current Liabilities 111.1B
Accounts Payable 24B
Accrued Liabilities 24.9B
Other Current Liabilities 62.2B
Non-Current Liabilities 44.1B
Long-Term Debt 20.2B
Other Non-Current Liabilities 23.8B
Efficiency

Earnings Waterfall
Rohto Pharmaceutical Co Ltd

Revenue
282.1B JPY
Cost of Revenue
-120.2B JPY
Gross Profit
161.8B JPY
Operating Expenses
-125B JPY
Operating Income
36.9B JPY
Other Expenses
-9.6B JPY
Net Income
27.3B JPY

Free Cash Flow Analysis
Rohto Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Rohto Pharmaceutical Co Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
58/100
Profitability
Score

Rohto Pharmaceutical Co Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Rohto Pharmaceutical Co Ltd's solvency score is 89/100. The higher the solvency score, the more solvent the company is.

89/100
Solvency
Score

Rohto Pharmaceutical Co Ltd's solvency score is 89/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Rohto Pharmaceutical Co Ltd

Wall Street analysts forecast Rohto Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Rohto Pharmaceutical Co Ltd is 4 059.6 JPY with a low forecast of 2 474.5 JPY and a high forecast of 5 008.5 JPY.

Lowest
Price Target
2 474.5 JPY
12% Downside
Average
Price Target
4 059.6 JPY
45% Upside
Highest
Price Target
5 008.5 JPY
78% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Rohto Pharmaceutical Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Rohto Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Rohto Pharmaceutical Co Ltd Logo
Rohto Pharmaceutical Co Ltd

Country

Japan

Industry

Consumer products

Market Cap

640.7B JPY

Dividend Yield

1.1%

Description

Rohto Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, cosmetics, and functional food items. The company is headquartered in Osaka, Osaka-Fu and currently employs 6,596 full-time employees. The firm primarily provides eye care-related products, including eye drops and eye lotions; skin care-related products, including dermatological preparations, lip balms, sunscreens and functional cosmetics; oral medication and food-related products, including digestive medicines, Chinese herbal medicines and supplements, as well as extracorporeal test drugs and other products. The firm operates its business in domestic market and overseas markets, including Europe, Asia and America.

Contact

OSAKA-FU
Osaka
1-8-1, Tatsumi-Nishi, Ikuno-ku
+81667581231.0
www.rohto.co.jp

IPO

1961-10-02

Employees

6 596

Officers

Chairman of the Board & CEO
Mr. Yamada Kunio
President, COO & Director
Mr. Masashi Sugimoto
EVP, CFO & Director
Mr. Saito Masaya
EVP, CTO & Director
Mr. Shinichi Kunisaki
Senior Executive Officer and General Manager of Marketing Division
Mr. Hideto Kamimura
CHRO & Director
Mr. Yasunori Kawasaki
Show More
MD, Chief Strategy Officer & Director
Hidetoshi Segi
Show Less

See Also

Discover More
What is the Intrinsic Value of one Rohto Pharmaceutical Co Ltd stock?

The intrinsic value of one Rohto Pharmaceutical Co Ltd stock under the Base Case scenario is 3 343.8 JPY.

Is Rohto Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 2 808.5 JPY, Rohto Pharmaceutical Co Ltd is Undervalued by 16%.

Back to Top